Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_assertion type Assertion NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_head.
- NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_assertion description "[Recently, we reported that carbamylated erythropoietin (CEPO) protected kidneys from ischemia reperfusion injury as well as EPO.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_provenance.
- NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_assertion evidence source_evidence_literature NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_provenance.
- NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_assertion SIO_000772 22410315 NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_provenance.
- NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_assertion wasDerivedFrom befree-2016 NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_provenance.
- NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_assertion wasGeneratedBy ECO_0000203 NP967051.RA0pQ4PsAogGM-CpwvmXIlEiB261-engrHZOc4UmRpmBY130_provenance.